Discover OncoCyte's Q4 2024 progress with its cutting-edge kidney transplant test. Insights on FDA ambitions, market strategies & financial runway.

The global luciferase assay market is set to experience robust growth, with its valuation projected to rise from USD 1,536.70 million in 2024 to USD 3,022.90 million by 2034, registering a CAGR of ...

A major biotech breakthrough is happening in New Orleans. Beken Bio, a biotech startup company that is soon to be based at ...

QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. Full text is unavailable for this digitized archive article. Subscribers may view the full text of this article in ...

Analyses of the manufacturer's more extensive data yielded similar results. The assay was reworked as a consequence, but was not removed from other markets during the interim period. NRL ...

A former Pokemon world champion says that the series' new competitive title, Pokemon Champions, could have a massive impact on the competition circuit. Wolfe Glick is a competitive Pokemon player ...

However, that success has not translated to competitive dominance, as the Video Game Championship (VGC) side of the main Pokémon games is still segmented from the casual fanbase. Pokémon VGC ...

The new World Bank report Driving Inclusive Growth in South Africa: Quick Wins with Competitive Markets and Efficient Institutions offers a positive message for South Africa. It asserts that a robust ...